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the “PreIoad Recruitable Stroke Work-Relation” (PRSW) in 24 anesthetized
open chest piga, 12 receiving in randomorder N050 ppm, PGEI 20 @ml and
their combination compared to 12controls. PHTwas induced by embolisation
with glasa beads (500#m). Prforto induction of PHTsonomicromatric crystals
were placed on the hearl to measure instantaneous cardiac dimensions. in-
stantaneous intraventricular pressure (micro-tip catheter) and intraventricular
dimensions were recorded digitally, while intraventricular volumes were cal-
culated from the intraventricular dimension applying the cylindric ellipsoidal
volume model for the left ventricle. PRSW was calculated from the instanta-
neous pressure and volume data during rapid vena caval occlusion by analy-
sis of generated pressure-volume Imps. All data were analyzed by MANOVA
and comectad for heart rate (level of significance #: p < 0.05; PRSW-slope
measures contractility, (PRSW-x-interceptdid not change significantly)
PRSW-change + SEM (% PHT)
NO vs. control PGEI VS. NO+ PGE1 V.%
#, p = 0.003 control control
PRSW: SIOP-S(verUM) –14.56*4.41 –8.77*4.59 -5.66*4.41
PRSW: slope (control) 1,63*4.48 0.98 *3.31 2.50&4.17
Appiioation of N050 ppm significantly reduced Ieftventricuiar contraofiiity
while PGEI 20 p~mi and the combination of NO 50 ppm and PGEI 20 @ml
did not. It is concluded that the combination of NO and PGEI forthetreatment
of puimonary hypertension should be considered for clinical application in
situations where a combination of pulmonaty hypertension and decreased
left ventricular function is present.
~0-1751 IS CO~OnaWStentinga~e~e~~Pti~ninP a,,,ative
Treatment of Cardiac Allograft Vasculopethy?
S.P.Jain, S. Zhang, S. Khosla, J.S. Jenkins, S.R. Ramee, M.R. Mehra,
H.O. Venture, D.D. Stapieton, N.E. McCaffhY,T.J. Coiiins. Ochsnerclinic,
New Orfeans, LA, USA
Elective coronary stenting is associated with excellent acute success, re-
duced restenosis rate and improved late clinical outcome in native coronaiy
atherosclerotic disease. However, its efficacy inpatients with cardiac aiiograft
vasculopathy (CAV) is not known. From 3/94 to &’96, ten pts (13 lesions) with
CAV underwent coronay stenting using Paimaz-Schatz stents (average size
3.4 mm, totai number = 14). The indications for PTCA were post Ml angina
(n= 2), unstable angina (n= 4), stabie angina (n = 3) and congestive hearl
faiiure (n = 1). The indication for stenting were e.uboptimal results (n = 3)
and eiecfive in (n = 10). The arteries stentad included LM = 1, LAD= 4, LCX
=2 and RCA =4. High pressure balloon dilatations were performed foilowing
initial stent deployment (mean atm 14). All pts were treatad with Aspirin 325
mg and Ticlopidine 500 m~day except 2 pts who received a combination of
Aspirin, Persantine, and Coumadin. Qualitative angiography was performed
using a automated edge detection technique (Arfrek). Procedural success
(< 30% residual diameter stenosis without Q wave Ml or death), in-hospital
implications and 6 months outcome were anaiyzed.
Results:
Pre Post
MinimalLuminslDiameter (mm) 0.63+0.28 3.40+ 0.56
Diamet6rstenosis (%) 42.5& 7.8 5.3*5.2
Acute Gain (mm) 2.60+ 0.6
Procedural success was achieved in all pts. There were no stent throm-
bosis, Q or non Q wave Mi, vascular complications or death prior to the
diecharge. Foilow-up angiography at six month was available in 7/10 pts and
none required target lesion revascularization.
Cone/us/ens:Coronary etenting in pts with CAV can be performed safeiy
with exeiient angiographic success and favorable iong-term results.
m910176 Naturally Occuring Leukopeniaas a Marker forGood Outcome After Cardiac Transplantation
J.A. Kobashigawa, G.A. Cogert, A. Sabad, H. Muhimeister, J.D. Cassem,
J. Moriguchi, N. Kawate, M.A. Hamiiton, A. Hage, D. Drfnkwater,H. Leks.
The University of California at Los Angel@s,Los Angelea, CA, USA
The mechanisms of graft toierancs are not well understood. It appears that
an immune suppression mechanism is responsible for this prooesa. in review
of 472 haarl transplant patients between 1984 and 1994, we have notad an
improved outcome for patients with naturally occurring Ieukopenia (WBC <
4000) more than 6 months after tranpelant deepite being discontinued from
ezathioprine and not having concomitant viral syndromea (cytomegalovirus)
or other extrineic WBC lowering causes. 14 patients with Ieukopenia (Group
A) were compared with 456 patients without Ieukopenia (Group B). Five year
aotuariai survival was 92~o in Group Avereus 69% in Group B (p < 0.05) (see
table). Similarly, 5 year freedom from transplant corona~ artery disease waa
greater in Group A versus Group B (85% versus 61%, respectively, p < 0.05).
First year rejection and infection incidence and demographic characteristics
inciuding recipiant and donor age, percent female, ischemic time, number
HLA mismatches, were not different between the two groups. All patientS
were initiaily treated with cyciosponne A based immunosuppression.
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Corrc/usion: Naturally occurring Ieukopenia in heart transplant patients
more than 6 months after transplant appears to be associat~ with graft
toierance by improved graft survival and freedom from transplant coronary
artery disease. Further investigation into the cause of this Ieukopenia is
warranted.
1910-1771 Management of Ischemiclieartt)isee.s ein
Patiants Referred for Cardiac Transplantation
C. Yancy,J. Escobar, M. Solomon, D. Meyer, S. Ring. UT Southwestern
Medical Center/St. Paul Medical Centec Dallas, TX, USA
Cardiac transplantation (CT) vs medical therapy (MT) or bypass grafting
(CABG) isdifficuittotriage inpts with ischemic heart disease (IHD). Question:
Does evidence of ischemia facilitate the decision of CT vs MT or CABG?
Methods: 79 pts (70 M, 9 F, age 53.7) referred for CT, with evidence of IHD,
(47% CABG, 53% e/p Mi), had V02 max, PCWP,and LVEF meaaurad. 49i79
had perfusion imaging study (SCAN). 30iT9 had active angina, (+) ETT, or
were too sick for assessment. Iechemia (iSCH) was defined as angina, (+)
SCAN, or (+) ETT. CABG was offered for suitabie anatomy and (+) ISCH;
MT was offered for pts with VOA >15 and (–) ISCH or unsuitable anatomy
for CABG; and CT was offered for pts with VOA <15. Endpoint was eurvival
at 1 year. Results:
MorWlity* LVEF V02 PCWP (+) SCAN (+) ISCH
MT (n =26) 7.7% 0.24 20 21 7/21 6/26
CASG (n = 12) 6.3”h 0.28 21 19 S1 6 12/12
CT (n = 31) 6.1”/0 o.17t 13t Zgt 4/14 5/31
WaitingCT (n = 10) 70%- O.lgt ,~t ~~t ze 4/10
Deaths (n= 10) - 0.20* 1st Zgt 416 6/10
*P= NSforMTVS CASG vs CT; **P < O.O5;tp <0.001 for CT or Death vs CABG or MT
/rnp: After adjusting for CABG, (+) SCAN or (+) ISCH did not predict
mortaiify. VOA mex was more predictive of outcome by multiple regression
anaiysis. Conclusion: Appropriate triage to MT/CABG ve CT can be best
done for pts with IHD based on measures of VOZ/PCWP and LVEF.
D910178 Heart Transplantation in Canada andDeterminants of Early and Late Mortality
R.A. Davies, M. Rivard, P.W.Pflugfelder, B. Jolain. University of Otfawa
Heart institute, Ottawa, Ontario, Canada, Canadian Heart Transplant
Centers, Canada
A muiticenter retrospective longitudinal study of patients who underwent first
adult heart transplant in Canada, since the introduction of cyclosporine, was
,conduotedin all ten centers. Between April 1961 and December 1992, 1083
patients underwent transplant. The role of 65 covariates on early (<90 day)
and iate mortality was assessed.
Mean age (+ SD) was 47 + 11 years (15-69 with 26% 55+. Diagnosis
was CAD in 49% (of whom 42% had CABG) and cardiomyopathy in 39%.
Mean donor age was 33 & 11years (10-63) with 13Y045+. Treated rejection
occurred in 72% of patients. Cholesterol rose from 176 + 58 mg/dl preop to
248 + 5S mg/dl one year postop.
Death occurred in 302 patients (159 early) and 19 ware retransplantad.
Causes of early death were perioperative graft failure 28%, rejection 23%,
infection 17%,CAD4% and other 28Y0.Late death was due to rejection 30%,
CAD 21%, infection 13%, cancer 8% and other 26%. Kaplan-Meier aurvival
rates at 1 and 5 years were 60Y. and 88Y0.
Univariate analysis of selectad variables among both earfy and late aur-
vivors showad increased mortality with both older donors (p < 0.0C05) and
female donore (p = 0.002, Tarone-Ware weighted Iogrank atatiatios). How-
ever female donors were older (Pearson Chi-square, p c 0.0005). Of donors
aged 45+ yeare, 21% were femaie and 10% were male.
Muitivariate anaiyeis of patients who survived more than 90 days showad
that older donor age (p < 0.0001), but not female gender, predicted increased
